Centene Corporation (NYSE: CNC) is one of 14 publicly-traded companies in the “Managed Health Care” industry, but how does it weigh in compared to its competitors? We will compare Centene Corporation to similar companies based on the strength of its earnings, risk, valuation, dividends, profitability, institutional ownership and analyst recommendations.

Institutional & Insider Ownership

92.7% of Centene Corporation shares are owned by institutional investors. Comparatively, 90.3% of shares of all “Managed Health Care” companies are owned by institutional investors. 3.0% of Centene Corporation shares are owned by company insiders. Comparatively, 2.4% of shares of all “Managed Health Care” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Centene Corporation has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Centene Corporation’s competitors have a beta of 0.76, suggesting that their average stock price is 24% less volatile than the S&P 500.

Earnings and Valuation

This table compares Centene Corporation and its competitors revenue, earnings per share and valuation.

Gross Revenue EBITDA Price/Earnings Ratio
Centene Corporation $43.65 billion $2.19 billion 19.35
Centene Corporation Competitors $52.70 billion $3.80 billion 18.44

Centene Corporation’s competitors have higher revenue and earnings than Centene Corporation. Centene Corporation is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Centene Corporation and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Centene Corporation 1.81% 14.79% 4.34%
Centene Corporation Competitors 1.69% 10.28% 3.36%

Analyst Recommendations

This is a breakdown of current ratings and target prices for Centene Corporation and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene Corporation 1 4 13 0 2.67
Centene Corporation Competitors 79 879 1442 23 2.58

Centene Corporation currently has a consensus price target of $95.88, indicating a potential upside of 1.56%. As a group, “Managed Health Care” companies have a potential downside of 4.05%. Given Centene Corporation’s stronger consensus rating and higher probable upside, equities analysts clearly believe Centene Corporation is more favorable than its competitors.

Summary

Centene Corporation beats its competitors on 9 of the 13 factors compared.

Centene Corporation Company Profile

Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.

Receive News & Ratings for Centene Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corporation and related companies with MarketBeat.com's FREE daily email newsletter.